Skip to main content

Table 2 Comparison of Previous history/findings between patients who died and who alive at 1 year

From: Impact of guideline-recommended versus non-guideline-recommended β-blocker and Doppler echocardiographic parameters on 1-year mortality in Thai ischemic cardiomyopathy patients: A prospective multicenter registry

Previous history/findingsDied
at 1 year
(n = 39)
Alive
at 1 year
(n = 357)
p-value
Chronic stable angina, n (%)4 (10.3%)29 (8.1%)0.552
Myocardial infarction, n (%)26 (66.7%)221 (61.9%)0.560
Peripheral vascular disease, n (%)3 (7.7%)12 (3.4%)0.175
NYHA FC 1, n (%)4 (11.1%)74 (21.7%) 
NYHA FC 2, n (%)18 (50.0%)209 (61.3%)0.012
NYHA FC 3, n (%)12 (33.3%)52 (15.2%) 
NYHA FC 4, n (%)2 (5.6%)6 (1.8%) 
Baseline HR (bpm), mean ± SD78.4 ± 17.177.1 ± 32.60.817
Target HR at 1 year (bpm), mean ± SD82.3 ± 16.373.3 ± 140.096
Baseline Systolic Blood Pressure, mmHg115.2 ± 23.2124.4 ± 19.80.007
Baseline Diastolic Blood Pressure, mmHg66.9 ± 11.771.2 ± 12.70.044
Systolic Blood pressure at 1 year, mmHg111.8 ± 11.2123.2 ± 19.20.094
Diastolic Blood pressure at 1 year, mmHg67 ± 10.470.4 ± 120.423
Electrocardiographic findings
 Sinus Rhythm, n (%)31 (83.8%)291 (87.7%)0.546
 Atrial fibrillation n (%)5 (13.5%)28 (8.4%) 
Rate (bpm), mean ± SD78.38 ± 15.6576.03 ± 18.900.468
PR interval (ms), median (max, min)177 (104, 999)175 (0, 909)0.320
QRS complex duration (ms), mean ± SD114.35 ± 30.77113.64 ± 27.510.883
Inferior leads (ІІ or ІІІ or aVF), n (%)14 (63.6%)88 (42.1%)0.053
Anterior leads (І or aVL), n (%)2 (9.1%)35 (16.7%)0.542
Lateral leads (V2-V5), n (%)14 (63.6%)150 (71.8%)0.424
Echocardiographic findings
LVEF (%) by Simpson’s method, mean ± SD26.7 ± 7.630.2 ± 7.80.021
LVESV, mean ± SD ml130.96 ± 56.83111.63 ± 50.980.046
LVEDV, mean ± SD ml185.8 ± 73.2155.6 ± 64.20.014
LVEF (%) by Teicholz’s method, mean ± SD29.27 ± 10.7032.01 ± 9.250.098
Mitral E wave velocity units, median (max, min) m/s89.7 (11.1, 250)64.1 (0.32, 167)0.040
Mitral A wave velocity, median (max, min) m/s61.6 (5.68, 124.2)66.1 (0.32, 149)0.753
Mitral deceleration time, mean ± SD ms142.9 ± 57.5182.4 ± 85.70.041
RVSP mmHg, mean ± SD45.58 ± 18.4540.64 ± 17.420.186
LV thrombus, n (%)3 (8.3%)15 (4.5%)0.402
  1. A p-value< 0.05 indicates statistical significance
  2. Abbreviations: NYHA FC New York Heart Association Functional Classification; bpm beats per minute; SD standard deviation; ms milliseconds; LBBB left bundle branch block; LVEF left ventricular ejection fraction; LVESV left ventricular end-systolic volume; LVEDV left ventricular end-diastolic volume; RVSP right ventricle systolic pressure